Get started
Author

Saul J. Priceman

Regression of Glioblastoma after Chimeric Antigen Receptor T-Cell Therapy
2016 · Christine E. Brown, Darya Alizadeh, et al. · New England Journal of Medicine · 1,836
PDF
The Sympathetic Nervous System Induces a Metastatic Switch in Primary Breast Cancer
2010 · Erica K. Sloan, Saul J. Priceman, et al. · Cancer Research · 921
PDF
CSF1R Signaling Blockade Stanches Tumor-Infiltrating Myeloid Cells and Improves the Efficacy of Radiotherapy in Prostate Cancer
2013 · Jingying Xu, Jemima Escamilla, et al. · Cancer Research · 569
A novel intracellular protein delivery platform based on single-protein nanocapsules
2009 · Ming Yan, Juanjuan Du, et al. · Nature Nanotechnology · 424
STAT3 Activation-Induced Fatty Acid Oxidation in CD8+ T Effector Cells Is Critical for Obesity-Promoted Breast Tumor Growth
2019 · Chunyan Zhang, Chanyu Yue, et al. · Cell Metabolism · 366
PDF
Targeting distinct tumor-infiltrating myeloid cells by inhibiting CSF-1 receptor: combating tumor evasion of antiangiogenic therapy
2009 · Saul J. Priceman, James L. Sung, et al. · Blood · 356
Regional Delivery of Chimeric Antigen Receptor–Engineered T Cells Effectively Targets HER2+ Breast Cancer Metastasis to the Brain
2017 · Saul J. Priceman, Dileshni Tilakawardane, et al. · Clinical Cancer Research · 327
Effective combination immunotherapy using oncolytic viruses to deliver CAR targets to solid tumors
2020 · Anthony K. Park, Yuman Fong, et al. · Science Translational Medicine · 271
PDF
S1PR1-STAT3 Signaling Is Crucial for Myeloid Cell Colonization at Future Metastatic Sites
2012 · Jiehui Deng, Yong Liu, et al. · Cancer Cell · 252
PDF
Targeting Alpha-Fetoprotein (AFP)–MHC Complex with CAR T-Cell Therapy for Liver Cancer
2016 · Hong Liu, Yiyang Xu, et al. · Clinical Cancer Research · 231
CSF1 Receptor Targeting in Prostate Cancer Reverses Macrophage-Mediated Resistance to Androgen Blockade Therapy
2015 · Jemima Escamilla, Shiruyeh Schokrpur, et al. · Cancer Research · 219
Chimeric Antigen Receptors With Mutated IgG4 Fc Spacer Avoid Fc Receptor Binding and Improve T Cell Persistence and Antitumor Efficacy
2014 · Mahesh Jonnalagadda, Armen Mardiros, et al. · Molecular Therapy · 204
Suppression of Prostate Cancer Nodal and Systemic Metastasis by Blockade of the Lymphangiogenic Axis
2008 · Jeremy B. Burton, Saul J. Priceman, et al. · Cancer Research · 167
PDF
Co-stimulatory signaling determines tumor antigen sensitivity and persistence of CAR T cells targeting PSCA+ metastatic prostate cancer
2017 · Saul J. Priceman, Ethan A. Gerdts, et al. · OncoImmunology · 166
PET of Adoptively Transferred Chimeric Antigen Receptor T Cells with 89 Zr-Oxine
2018 · Michael R. Weist, Renate Starr, et al. · Journal of Nuclear Medicine · 159
PDF
CTLA4 aptamer delivers STAT3 siRNA to tumor-associated and malignant T cells
2014 · Andreas Herrmann, Saul J. Priceman, et al. · Journal of Clinical Investigation · 153
PDF
Enhanced intratumoural activity of CAR T cells engineered to produce immunomodulators under photothermal control
2021 · Ian C. Miller, Ali Zamat, et al. · Nature Biomedical Engineering · 148
Pten Null Prostate Epithelium Promotes Localized Myeloid-Derived Suppressor Cell Expansion and Immune Suppression during Tumor Initiation and Progression
2014 · Alejandro J. Garcia, Marcus Ruscetti, et al. · Molecular and Cellular Biology · 142
PDF
Effective Targeting of TAG72+ Peritoneal Ovarian Tumors via Regional Delivery of CAR-Engineered T Cells
2018 · John P. Murad, Anna K. Kozlowska, et al. · Frontiers in Immunology · 141
PDF
PSCA-CAR T cell therapy in metastatic castration-resistant prostate cancer: a phase 1 trial
2024 · Tanya B. Dorff, M. Suzette Blanchard, et al. · Nature Medicine · 139
Off-the-Shelf Prostate Stem Cell Antigen–Directed Chimeric Antigen Receptor Natural Killer Cell Therapy to Treat Pancreatic Cancer
2022 · Kun-Yu Teng, Anthony G. Mansour, et al. · Gastroenterology · 136
Targeting advanced prostate cancer with STEAP1 chimeric antigen receptor T cell and tumor-localized IL-12 immunotherapy
2023 · Vipul Bhatia, Nikhil V. Kamat, et al. · Nature Communications · 131
PDF
PD-L1 blockade restores CAR T cell activity through IFN-γ-regulation of CD163+ M2 macrophages
2022 · Yukiko Yamaguchi, Jackson Gibson, et al. · Journal for ImmunoTherapy of Cancer · 126
PDF
Regulation of adipose tissue T cell subsets by Stat3 is crucial for diet-induced obesity and insulin resistance
2013 · Saul J. Priceman, Maciej Kujawski, et al. · Proceedings of the National Academy of Sciences · 119
Icaritin Inhibits JAK/STAT3 Signaling and Growth of Renal Cell Carcinoma
2013 · Shasha Li, Saul J. Priceman, et al. · PLoS ONE · 117
PDF
Works count: 209
Citation count: 9,146
H-index: 35
I10-index: 59
Year
Topic
Type